medigraphic.com
Boletín Médico del Hospital Infantil de México

2005, Number 1

<< Back Next >>

Bol Med Hosp Infant Mex 2005; 62 (1)

Síndrome de Stevens-Johnson. Informe de 7 casos

Sotelo-Cruz N, Hurtado-Valenzuela JG, Rascón-Alcantar A

Language: Spanish
References: 15
Page: 25-32
PDF size: 301.48 Kb.


ABSTRACT




REFERENCES

  1. Ghislain PD, Roujeau JC. Treatment severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hysersensitivity syndrome dermotology. On Line J. 2002; 8: 5.

  2. Rzany B, Correio O, Kelly JP, Auquier A, Stern R. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first week of antiepileptic therapy: a case control study. Lancet. 1999; 353: 2190-4.

  3. Hallgren J, Tengavall-Linder M, Persson M, Wahlgren CF. Stevens-Johnson syndrome associated with ciprofloxacin: a review of adverse cutaneous event reported in Sweden as associated with this drug. J Am Acad Dermatol. 2003; 49: Suppl: S267-9.

  4. Metry DW, Lahart CJ, Farmer KL, Herbert AA. Stevens-Johnson syndrome caused by antiretroviral drug nevirapine. J Am Acad Dermatol. 2001; 44 Suppl 2: 354-7.

  5. Parrillo SJ, Parrillo CV. Stevens-Johnson syndrome 2004 Sept 2004. http://www.emedicine.com/emerg/topic 555.htm.

  6. Ball R, Ball LK, Braun MM, Beeler JA, Salvie ME. Stevens-Johnson syndrome and toxic epidermal necrolysis after vaccination: reports to the vaccine adverse event reporting system. Pediatr J Infect Dis. 2001; 20: 219-21.

  7. Fritsh PO, Ruíz-Maldonado R. Stevens-Johnson syndrome toxic epidermal necrolysis. En: Freedberg IM, Eisen AZ, Wolf K, editores. Fitspatrick’s dermatology in general medicine. New York: McGraw-Hill; 1999. p. 636.

  8. Hazir T, Saleem M, Abbas KA. Stevens-Johnson syndrome fallowing measles vaccination. J Pak Med Assoc. 1997; 47: 264-5.

  9. Paquet P, Pierard GE. Erythema multiform and toxic epidermal necrolysis: a comparative study. Am J Dermatopathol. 1997; 19: 127-32.

  10. Gamboa-Marrufo JD, Suárez-Mattus A. Síndrome de Stevens-Johnson. En: Rodríguez SR, editor. Urgencias en pediatría. 4ª ed. México: Interamericana Mc Graw-Hill; 1996. p. 616-20.

  11. Koopmans PP, Vander-Ven AJ, Uree TB, Vander-Meer JW. Pathogenesis of hypersensitivity reactions to drugs in patients with HIV infection: alergic or toxic? AIDS. 1995; 9: 217-22.

  12. Bastuji-Gran S, Fouchard N, Bertocci M. SCORTEN: A severity of illness score for toxic epidermal necrolysis. J Invest Dermatol. 2000; 115: 149-53.

  13. Wierner JS, Tucker JA, Walther PJ. Interlukin-2-induced dermatotoxicity resembling toxic epidermal necrolysis. South Med J. 1992; 85: 656-9.

  14. Murphy GF. Piel. En: Kumar C, editor. Patología humana. México: Ed. Mc Graw-Hill Interamericana; 1999. p. 753-6.

  15. García-Doral I, Lecleach L, Bocquet H, Otero XL, Rojeau JC. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Does early withdrawal of causative drugers decrease the risk of death? Arch Dermatol. 2000; 136: 326-7.




2020     |     www.medigraphic.com